TECX Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. (TECX) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $1.38 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +13.4% since its last earnings release on August 6, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Tectonic Therapeutic, Inc.
Tectonic Therapeutic Inc. is a biotechnology company developing GPCR -targeted therapeutic proteins. Tectonic Therapeutic Inc., formerly known as AVROBIO Inc., is based in CAMBRIDGE, Mass.
Sector
Healthcare
Industry
Biotechnology